founder
Tonix Pharma
A decision maker and a leader in global research and development. Well-experienced in using new and complex technologies to effectively translate scientific discovery into products. Discovered and developed vaccines and therapeutics for multiple infectious diseases. Deep understanding of regulatory path for neglected diseases and pharmaceuticals. Initiated and led programs at all stages of discovery and development. Adept at providing and communicating strategies and technical leadership in dynamic and highly matrixed environments. Quickly overcame obstacles by making bridges between diverse groups of researchers and decision-makers. An international leader and key architect of multiple operational and strategic teams. A member of WHO Blueprint for Deadly Pathogens. Provided scientific and strategic leadership for multiple teams varying in size from 12-500 people. Dr. Bavari was appointed Executive Vice President, at Tonix Pharmaceuticals in July 2022. Dr. Bavari was the CSO and co-founder of Healion Bio. and served as CSO at the USAMRIID.